ORA:NYSEOrmat Technologies, Inc. Analysis
Data as of 2026-04-22 - not real-time
$107.12
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Ormat Technologies is trading near a key support level while technical indicators show mixed signals. The 20‑day and 50‑day moving averages are closely aligned, suggesting a neutral trend, but the MACD is in a bearish configuration and the RSI sits in the lower‑mid range, hinting at potential oversold conditions. Volume has been trending upward, adding momentum to the price action. The stock’s beta is below one, indicating lower relative volatility compared with the broader market, yet the recent 30‑day price swings remain elevated. The market price sits above the discounted cash‑flow derived fair value, implying that the equity may be priced at a premium.
Fundamentally, the company delivers solid top‑line growth and maintains a modest dividend yield with a comfortable payout ratio, but free cash flow is currently negative and leverage is high, raising concerns about cash sustainability. Its price‑to‑earnings multiple is substantially higher than the industry average, reinforcing the overvaluation view. Nevertheless, the renewable‑energy sector’s favorable regulatory backdrop and Ormat’s diversified geothermal footprint provide a growth narrative. With an analyst consensus tilted to buy and a target price that suggests upside, the near‑term catalyst will be the upcoming earnings release. Investors should weigh the blend of growth potential against valuation and balance‑sheet risks.
Fundamentally, the company delivers solid top‑line growth and maintains a modest dividend yield with a comfortable payout ratio, but free cash flow is currently negative and leverage is high, raising concerns about cash sustainability. Its price‑to‑earnings multiple is substantially higher than the industry average, reinforcing the overvaluation view. Nevertheless, the renewable‑energy sector’s favorable regulatory backdrop and Ormat’s diversified geothermal footprint provide a growth narrative. With an analyst consensus tilted to buy and a target price that suggests upside, the near‑term catalyst will be the upcoming earnings release. Investors should weigh the blend of growth potential against valuation and balance‑sheet risks.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- price near support
- increasing volume
- oversold RSI
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- high valuation relative to peers
- negative free cash flow
- upcoming earnings catalyst
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- renewable energy tailwinds
- global geothermal footprint
- elevated debt levels
Key Metrics & Analysis
Financial Health
Revenue Growth19.60%
Profit Margin12.52%
P/E Ratio53.0
ROE4.84%
ROA1.76%
Debt/Equity106.16
P/B Ratio2.6
Op. Cash Flow$335.1M
Free Cash Flow$-290771264
Industry P/E22.0
Technical Analysis
TrendNeutral
RSI39.4
Support$107.10
Resistance$117.33
MA 20$112.01
MA 50$112.27
MA 200$105.96
MACDBearish
VolumeIncreasing
Fear & Greed Index87.02
Valuation
Fair Value$72.12
Target Price$127.09
Upside/Downside18.64%
GradeOvervalued
TypeGrowth
Dividend Yield0.44%
Risk Assessment
Beta0.73
Volatility27.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.